KYKOF (Kyowa Kirin Co) 5-Year Yield-on-Cost %: 4.13 (As of Jul. 10, 2026) — 77% Above Median


KYKOF Kyowa Kirin Co Ltd KYKOF
82 GF Score
Price $14.43
GF Value $17.76
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kyowa Kirin Co 5-Year Yield-on-Cost %?

Kyowa Kirin Co KYKOF 82 5-Year Yield-on-Cost % is 4.13 as of Jul. 10, 2026, which is 77% above its 10-year median of 2.33. GuruFocus rates KYKOF with a GF Score™ of 82/100 and a GF Value™ of $17.76 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 516 Drug Manufacturers companies, Kyowa Kirin Co ranks better than 62.98% on this metric.

Kyowa Kirin Co's yield on cost for the quarter that ended in Dec. 2025 was 4.13.


The historical rank and industry rank for Kyowa Kirin Co's 5-Year Yield-on-Cost % or its related term are showing as below:

KYKOF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.53   Med: 2.33   Max: 4.13
Current: 4.13


During the past 13 years, Kyowa Kirin Co's highest Yield on Cost was 4.13. The lowest was 1.53. And the median was 2.33.


KYKOF's 5-Year Yield-on-Cost % is ranked better than
62.98% of 516 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs KYKOF: 4.13

Kyowa Kirin Co  (OTCPK:KYKOF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Kyowa Kirin Co 5-Year Yield-on-Cost % Related Terms


KYKOF vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kyowa Kirin Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's 5-Year Yield-on-Cost % falls into.


KYKOF
82GF Score
Kyowa Kirin Co Ltd KYKOF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyowa Kirin Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Kyowa Kirin Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 4.13 mean?
Kyowa Kirin Co (KYKOF) has a 5-Year Yield-on-Cost % of 4.13 as of Jul. 10, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Kyowa Kirin Co and its competitors. This is 77% above median its historical median of 2.33. Over the past decade, Kyowa Kirin Co's 5-Year Yield-on-Cost % has ranged from 1.53 to 4.13. According to the industry distribution chart, Kyowa Kirin Co ranks #191 out of 516 companies in the Drug Manufacturers industry, placing it in the top 37%.
Is Kyowa Kirin Co's 5-Year Yield-on-Cost % too high?
Kyowa Kirin Co's current 5-Year Yield-on-Cost % of 4.13 is 77% above median its 10-year median of 2.33. Over the past 10 years, this metric has ranged from a low of 1.53 to a high of 4.13. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.24. Kyowa Kirin Co's value of 4.13 is 84.4% above this industry median. Based on the distribution chart, Kyowa Kirin Co ranks #191 out of 516 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kyowa Kirin Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kyowa Kirin Co ranks #191 out of 516 companies for 5-Year Yield-on-Cost %. This puts Kyowa Kirin Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.24. Kyowa Kirin Co's value of 4.13 is 84.4% above this benchmark. Historically, Kyowa Kirin Co's own 5-Year Yield-on-Cost % has ranged from 1.53 to 4.13 over the past decade. While the company's 10-year median is 2.33 vs. the industry median of 2.24, Kyowa Kirin Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.24, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kyowa Kirin Co's current 5-Year Yield-on-Cost % of 4.13 is 84.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Kyowa Kirin Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kyowa Kirin Co's current 5-Year Yield-on-Cost % is 4.13, which is 77% above median its own 10-year median of 2.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (KYKOF) is currently considered Modestly Undervalued. The stock's GF Value™ is $17.76, compared to a current price of $14.43 — trading 18.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 4.13, which is 77% above median its 10-year median of 2.33 and 84.4% above the Drug Manufacturers industry median of 2.24. Kyowa Kirin Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Kyowa Kirin Co (KYKOF), the current 5-Year Yield-on-Cost % is 4.13 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyowa Kirin Co (KYKOF) Overvalued in 2026?

Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued. The current stock price of $14.43 is trading 18.8% below its estimated GF Value™ of $17.76. GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.

Key valuation signals for KYKOF:

  • 5-Year Yield-on-Cost %: 4.13 (77% above median its 10-year median of 2.33)
  • GF Value™: $17.76 vs. price of $14.43 (18.8% below fair value)
  • GF Score™: 82/100 with 1 warning sign
  • Industry Position: 84.4% above the Drug Manufacturers median (#191 of 516)

No single metric tells the full story. See the KYKOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kyowa Kirin Co Business Description

Address 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
82GF Score

Get the complete analysis for KYKOF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.43
Price
$17.76
GF Value